Your session is about to expire
← Back to Search
rTMS for Obsessive-Compulsive Disorder
Study Summary
This trial will study how brain activity affects OCD, and test new treatments to see if they help.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had a device implanted or undergone brain surgery.I have a history of significant hearing loss.I have a serious brain or nerve condition.My OCD symptoms started after I turned 40.My head or neck movements interfere with certain medical scans.I have a history of brain-related health issues or a close relative with seizures.I have been diagnosed with severe Personality Disorder or was hospitalized for borderline personality disorder.My medication affecting brain activity is approved by a TMS specialist.I am between 18 and 80 years old.I have tried or refused standard OCD treatments.I have been diagnosed with OCD and it's moderately severe.I am not on antidepressants or have been on a stable dose for 8 weeks.I am not currently hospitalized.I understand and can agree to the study's procedures and risks.I plan to start or have recently started Cognitive Behavioral Therapy.I do not have any unstable health conditions.My aTBS treatment dose is over 65% of the maximum output.I have bipolar disorder or have had manic episodes.
- Group 1: Medial Prefrontal Cortex (MPFC)
- Group 2: Right Prefrontal Cortex (rPFC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available in this trial for individuals seeking treatment?
"Affirmative. According to clinicaltrials.gov, this research project is in full recruitment mode as of April 24th 2023. Initially posted on March 14th 2022, it aims to enrol 360 participants from two distinct medical centres."
Am I eligible to join this research endeavor?
"This clinical trial seeks to enrol 360 participants, who must be between 18 and 80 years old with a diagnosis of obsessive-compulsive disorder."
How many participants are part of this clinical experiment?
"Yes, the trial is currently open for enrollment. As per information on clinicaltrials.gov, this study was first uploaded on March 14th of 2022 and most recently updated April 24th 2023. The research team seeks 360 participants across two distinct locations."
Is this investigation open to those aged 55 and above?
"This trial only enrols patients aged 18 to 80. Those younger than 18 can join one of the 22 trials available, while those older than 65 are able to choose from 69 medical studies."
Share this study with friends
Copy Link
Messenger